Uncompromising Quality: Manufactured under sterile standards with FDA-compliant natural ingredients
The safety and effectiveness of BPC-157 have not been thoroughly evaluated in humans
Tissue regeneration : including promotion of fibroblast migration, increased collagen synthesis, angiogenesis (new blood vessel growth), etc
But in practice, and especially with regard to synthetic and recombinant peptide forms, there are some considerable potential safety concerns: Immunogenicity Most notably, per a 2020 assessment on therapeutic peptide safety, synthetic and recombinant peptides pose the risk of immunogenicity the ability of a substance to provoke an immune response.15 An immunogenicity-inducing peptide, when introduced to the body, would cause the bodys immune system to perceive the peptide not as a medication but as a threat
(Contains description of formulation, indications, dosing, and storage recommendations)